EDGAR Filing Documents for 0001279569-15-001814

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-15-001814

Filing Date

2015-09-14

Accepted

2015-09-14 10:19:29

Documents

Period of Report

2015-09-14

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	transitionthera6k.htm	6-K	10860
2	NEWS RELEASE DATED SEPTEMBER 14, 2015	ex991.htm	EX-99.1	4302
	Complete submission text file	0001279569-15-001814.txt		16166

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7

Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770

Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 151104846
SIC: 2833 Medicinal Chemicals & Botanical Products